AAV-Mediated Gene Delivery to 3D Retinal Organoids Derived from Human Induced Pluripotent Stem Cells
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Human induced pluripotent stem cells (hiPSCs) promise a great number of future applications to investigate retinal development, pathophysiology and cell therapies for retinal degenerative diseases. Specific approaches to genetically modulate hiPSC would be valuable for all of these applications. Vectors based on adeno-associated virus (AAV) have shown the ability for gene delivery to retinal organoids derived from hiPSCs. Thus far, little work has been carried out to investigate mechanisms of AAV-mediated gene delivery and the potential advantages of engineered AAVs to genetically modify retinal organoids. In this study, we compared the early transduction efficiency of several recombinant and engineered AAVs in hiPSC-derived RPE cells and retinal organoids in relation to the availability of their cell-surface receptors and as a function of time. The genetic variant AAV2-7m8 had a superior transduction efficiency when applied at day 44 of differentiation on retinal organoids and provided long-lasting expressions for at least 4 weeks after infection without compromising cell viability. All of the capsids we tested transduced the hiPSC-RPE cells, with the AAV2-7m8 variant being the most efficient. Transduction efficiency was correlated with the presence of primary cell-surface receptors on the hiPS-derived organoids. Our study explores some of the mechanisms of cell attachment of AAVs and reports long-term gene expression resulting from gene delivery in retinal organoids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Table summarizing adeno-associated virus (AAV) receptors, co-receptors and cell tropism of commonly used serotypes after subretinal administration in murine [23,24,25] and primate retina [26]. FGFR1: Fibroblast Growth Factor Receptor 1. LAMR1: Laminin Receptor 1.](https://figures.cochat.ai/paper-figures/164331c54e6d4a85b2d1210aba12db85/aav-mediated-gene-delivery-to-3d-retinal-organoids-derived-from-human-induced-figure-1.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly though, (early) radial retinal progenitor cells in retinal organoids or common cell lines can efficiently be infected by rAAV6, the rAAV6 variants (ShH10 and ShH10Y-445F), and the AAV2-7m8 [21,62,265,284].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [284]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“rAAV2-7m8 and rAAV5 also efficiently infected RPE cells [265,284].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [284]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“confirming its effectiveness as a vector for retinal transduction and supporting its clinical utility (28, 31).”
From Characterization of RNA editing and gene therapy with a compact CRISPR-Cas13 in the retina (2024) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is likely due to the reported preferential transduction of RPE cells by the AAV2.7m8 serotype (28).”
From Characterization of RNA editing and gene therapy with a compact CRISPR-Cas13 in the retina (2024) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, the poor transfection efficiency of rAAV9 of retinal organoids [62,265] was linked to the low abundance of N-linked-galactose at early retinal developmental stages [284].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [284]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Organoid Models and Applications in Biomedical Research
Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · Nephron · doi:10.1159/000433566 · Cited by 3,515
Self-formation of optic cups and storable stratified neural retina from human ESCs
Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., Saito, K., Yonemura, S., Eiraku, M., & Sasai, Y. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.009 · Cited by 1,447
Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs
Zhong, X., Gutierrez, C., Xue, T., Hampton, C., Vergara, M. N., Cao, L.-H., Peters, A., Park, T. S., Zambidis, E. T., Meyer, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5047 · Cited by 970
Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005708 · Cited by 734 · cited 2×
“AAV2-7m8 was more efficient in gene delivery to retinal organoids despite the fact that it shares common cell surface receptors with its parental capsid AAV2 [16].”
BackgroundSelf-citationModeling early retinal development with human embryonic and induced pluripotent stem cells
Meyer, J. S., Shearer, R. L., Capowski, E. E., Wright, L. S., Wallace, K. A., McMillan, E. L., Zhang, S.-C., & Gamm, D. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905245106 · Cited by 601
An essential receptor for adeno-associated virus infection
Pillay, S., Meyer, N. L., Puschnik, A. S., Davulcu, O., Diep, J., Ishikawa, Y., Jae, L. T., Wosen, J. E., Nagamine, C. M., Chapman, M. S., et al. (2016) · Nature · doi:10.1038/nature16465 · Cited by 532 · cited 1×
“The recently discovered AAVR (KIAA0319L), recognized as a universal AAV receptor, was also included in the present study [22].”
BackgroundCarr, A.-J., Vugler, A. A., Hikita, S. T., Lawrence, J. M., Gias, C., Chen, L. L., Buchholz, D. E., Ahmado, A., Semo, M., Smart, M. J. K., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008152 · Cited by 413
Cearley, C. N., & Wolfe, J. H. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.015 · Cited by 409 · cited 1×
“There are over one hundred naturally occurring AAV variants and ten distinct rAAV serotypes differing in their natural tropism towards cells [10].”
BackgroundAuricchio, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3075 · Cited by 403
From confluent human iPS cells to self-forming neural retina and retinal pigmented epithelium
Reichman, S., Terray, A., Slembrouck, A., Nanteau, C., Orieux, G., Habeler, W., Nandrot, E. F., Sahel, J.-A., Monville, C., & Goureau, O. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324212111 · Cited by 300 · cited 2×
“Optimization of previous protocols [3,27] allowed the generation of retinal organoids from human iPSC.”
BackgroundMethodSelf-citation
Cited by
Bucher, K., Rodríguez-Bocanegra, E., Dauletbekov, D., & Fischer, M. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100915 · Cited by 242
Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids
Lane, A., Jovanovic, K., Shortall, C., Ottaviani, D., Panes, A. B., Schwarz, N., Guarascio, R., Hayes, M. J., Palfi, A., Chadderton, N., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.05.007 · Cited by 181
“, antibody versus intrinsic fluorescence of a reporter (Garita-Hernandez et al., 2020; Gonzalez-Cordero et al., 2018; Quinn et al., 2019).”
BackgroundO’Carroll, S. J., Cook, W. H., & Young, D. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.618020 · Cited by 107
A look into retinal organoids: methods, analytical techniques, and applications
Afanasyeva, T. A. V., Corral-Serrano, J. C., Garanto, A., Roepman, R., Cheetham, M. E., & Collin, R. W. J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03917-4 · Cited by 117
Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration
Campostrini, G., Windt, L. M., van Meer, B. J., Bellin, M., & Mummery, C. L. (2021) · Circulation Research · doi:10.1161/circresaha.121.318183 · Cited by 96
Buck, T., & Wijnholds, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124197 · Cited by 92
“For example, rAAV6 and rAAV-derived vectors (ShH10; ShH10-Y445F) infected hiPSCs and hiPSC-derived RPE cells properly and thoroughly [21,62,265]. rAAV2-7m8 and rAAV5 also efficiently infected RPE cells [265,284].”
BackgroundInfluentialOrganoids and organ chips in ophthalmology
Manafi, N., Shokri, F., Achberger, K., Hirayama, M., Mohammadi, M. H., Noorizadeh, F., Hong, J., Liebau, S., Tsuji, T., Quinn, P. M. J., et al. (2020) · The Ocular Surface · doi:10.1016/j.jtos.2020.11.004 · Cited by 87
“AAV uptake may be a critical consideration for efficient transduction of RO cell types and therefore AAV vector choice [72,128].”
BackgroundHuang, Q., Chen, A. T., Chan, K. Y., Sorensen, H., Barry, A. J., Azari, B., Zheng, Q., Beddow, T., Zhao, B., Tobey, I. G., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002112 · Cited by 89
Rodrigues, A., Slembrouck-Brec, A., Nanteau, C., Terray, A., Tymoshenko, Y., Zagar, Y., Reichman, S., Xi, Z., Sahel, J., Fouquet, S., et al. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-022-00235-6 · Cited by 87
“The variant AAV7m8 was chosen for its high transduction ef fi ciency and long-lasting expression after infection without compromising cell viability when applied to iPSC-derived retinal organoids 38,39 .”
BackgroundSelf-citationAchberger, K., Cipriano, M., Duechs, M. J., Schön, C., Michelfelder, S., Stierstorfer, B., Lamla, T., Kauschke, S. G., Chuchuy, J., Roosz, J., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.08.008 · Cited by 81
“, 2018) and analyzing mechanisms of cell attachment and their interplay with primary cell-surface receptors (Garita-Hernandez et al., 2020).”
BackgroundOptogenetic Gene Therapy for the Degenerate Retina: Recent Advances
McClements, M. E., Staurenghi, F., MacLaren, R. E., & Cehajic-Kapetanovic, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.570909 · Cited by 69
“…relatively poor transduction efficiencies (2–20%), including AAV2, ShH10, AAV5, AAV8, AAV8 Y733F, and AAV9 with the most encouraging variant appearing to be AAV2(7m8), achieving up to 60% transduction efficiency (Gonzalez-Cordero et al., 2017; Khabou et al., 2018; Garita-Hernandez et al., 2020).”
BackgroundAAV for Gene Therapy in Ocular Diseases: Progress and Prospects
He, X., Fu, Y., Ma, L., Yao, Y., Ge, S., Yang, Z. H., & Fan, X. (2023) · Research · doi:10.34133/research.0291 · Cited by 79
“AAVR, also known as KIAA0319L, is a newly identified multiserotype AAV receptor that is essential for AAV transduction and is found in a variety of organs, including the liver, lung, kidney, and retina [59,60].”
BackgroundDepla, J. A., Sogorb-González, M., Mulder, L. A., Heine, V., Konstantinova, P., van Deventer, S., Wolthers, K., Pajkrt, D., Sridhar, A., & Evers, M. (2020) · Molecular Therapy: Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.028 · Cited by 37
“Comparably, retinal organoids, which are similar to cerebral organoids in their differentiation method, have been used to compare AAV serotypes for retinal gene therapy, suggesting the prospect for testing gene therapy approaches in brain organoids.(3,18) Finally, cerebral organoids have been shown to be susceptible t…”
MethodGeneration of ‘semi-guided’ cortical organoids with complex neural oscillations
Fitzgerald, M. Q., Chu, T., Puppo, F., Blanch, R., Chillón, M., Subramaniam, S., & Muotri, A. R. (2024) · Nature Protocols · doi:10.1038/s41596-024-00994-0 · Cited by 50
Exploiting CRISPR Cas9 in Three-Dimensional Stem Cell Cultures to Model Disease
Gopal, S., Rodrigues, A. L., & Dordick, J. S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00692 · Cited by 50
“Nevertheless, viral vectors are being employed together with nucleofection and electroporation to deliver genes to spheroid and organoid cultures (Matano et al., 2015; Bian et al., 2018; Garita-Hernandez et al., 2020).”
BackgroundRetinal organoids as models for development and diseases
Zhang, X., Wang, W., & Jin, Z. (2021) · Cell Regeneration · doi:10.1186/s13619-021-00097-1 · Cited by 47
Wagstaff, E. L., Berzal, A. H., Boon, C. J. F., Quinn, P. M. J., ten Asbroek, A. L. M. A., & Bergen, A. A. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137081 · Cited by 52
“DAPT, the γ-secretase inhibitor involved in notch signaling (Figure 6), is routinely added to improve photoreceptor differentiation and maturation [186,230,248].”
BackgroundKurzawa‐Akanbi, M., Tzoumas, N., Corral-Serrano, J. C., Guarascio, R., STEEL, D. H., Cheetham, M. E., Armstrong, L., & Lako, M. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101248 · Cited by 44
Optimized Adeno-Associated Virus Vectors for Efficient Transduction of Human Retinal Organoids
Völkner, M., Pavlou, M., Büning, H., Michalakis, S., & Karl, M. (2021) · Human Gene Therapy · doi:10.1089/hum.2020.321 · Cited by 42
Tropism of AAV Vectors in Photoreceptor-Like Cells of Human iPSC-Derived Retinal Organoids
McClements, M. E., Steward, H., Atkin, W., Goode, E. A., Gándara, C., Chichagova, V., & MacLaren, R. E. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.4.3 · Cited by 36
Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies
Ramamurthy, R. M., Atala, A., Porada, C. D., & Almeida-Porada, G. D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1011143 · Cited by 36
Research Models and Gene Augmentation Therapy for CRB1 Retinal Dystrophies
Boon, N., Wijnholds, J., & Pellissier, L. P. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00860 · Cited by 36
McNerney, C., & Johnston, R. J. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2021.03.001 · Cited by 31
Yu, J., Yin, Y., Leng, Y., Zhang, J., Wang, C., Chen, Y., Li, X., Wang, X., Liu, H., Liao, Y., et al. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114842 · Cited by 32
Botto, C., Dalkara, D., & El-Amraoui, A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.737632 · Cited by 32
“GL were shown to display an improved capacity to transduce retinal photoreceptor cells (Cronin et al., 2014; Byrne et al., 2020; Garita-Hernandez et al., 2020; Pavlou et al., 2021) and some of these have also the capacity to transduce efficiently the auditory hair cells (Landegger et al.”
BackgroundSelf-citationPerdigão, P. R. L., Ollington, B., Hali, S., Leung, A., Sacristán-Reviriego, A., & van der Spuy, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065912 · Cited by 29
“Furthermore, the efficacy of different AAV serotypes has been measured in RO, with AAV7m8 [34], and AAV2/2 [35] shown to produce the strongest transduction in each respective study.”
BackgroundThe Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease
Velazquez, L. A. M., & Ballios, B. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111542 · Cited by 28
“Human retinal organoids, which are self-organizing retinal tissue differentiated from induced pluripotent stem cells (this topic will be further discussed in the cell replacement therapies section), now allow for the testing of vector tropisms in human photoreceptors [131,132].”
BackgroundThe Rise of Retinal Organoids for Vision Research
Sharma, K., Krohne, T. U., & Busskamp, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228484 · Cited by 29
“One such study conducted recently indicates that AAV2-7m8 has superior transduction, possibly due to higher infectiousness and effective activation of secondary receptors [69].”
BackgroundBucher, K., Rodríguez‐Bocanegra, E., Wissinger, B., Straßer, T., Clark, S. J., Birkenfeld, A. L., Siegel-Axel, D. I., & Fischer, M. D. (2023) · Scientific Reports · doi:10.1038/s41598-023-28830-7 · Cited by 28
“In this study we demonstrate that (1) AAV8 and AAV2 induce lot-specific innate immune responses in human pDCs which are neither specific to the capsid/vg ratio nor the production platform nor the manufacturer/purification method; (2) innate immune responses in pDCs are dependent on TLR9 signalling and can be reduced b…”
MethodLee, Y. J., & Jo, D. H. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10802-7 · Cited by 27
“In this context, ROs have been utilized to assess various proper - ties of AAV vectors, including their tropism, transduction efficiency, and safety profiles [139 –141].”
Dash, B. C., Korutla, L., Vallabhajosyula, P., & Hsia, H. C. (2022) · Advances in Wound Care · doi:10.1089/wound.2021.0049 · Cited by 27
Retinal organoid light responsivity: current status and future opportunities
Onyak, J. R., Vergara, M. N., & Renna, J. M. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.001 · Cited by 27
Abulimiti, A., Lai, M. S., & Chang, R. C. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111549 · Cited by 23
de Lemos, L., Antas, P., Ferreira, I. S., Santos, I. P., Felgueiras, B., Gomes, C. M., Brito, C., Seabra, M. C., & Tenreiro, S. (2024) · In vitro models · doi:10.1007/s44164-024-00068-1 · Cited by 24
Organoids – the future of pre-clinical development of AAV gene therapy for CNS disorders
Kaiser, V., & Gonzalez-Cordero, A. (2025) · Gene Therapy · doi:10.1038/s41434-025-00527-8 · Cited by 21
“Westhaus et al., identi fi ed that AAV2(7m8) transduced retinal organoids, murine retina and primary and iPSC-derived RPE cells with the most ef fi ciency at both cellular entry and transgene levels, thus supporting previous data that this is the most ef fi cient retinal capsid [51, 55].”
Garita‐Hernandez, M., Chaffiol, A., Guibbal, L., Routet, F., Khabou, H., Riancho, L., Toualbi, L., Picaud, S. A., Sahel, J., Goureau, O., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.648210 · Cited by 21
“3D retinal organoids were optogenetically-transformed with the recombinant AAV2-7m8 capsid variant selected for its improved performance in retinal organoids when compared to other capsids also known for their tropism towards cones (Garita-Hernandez et al., 2020).”
BackgroundSelf-citationGene Therapy for Rhodopsin-associated Autosomal Dominant Retinitis Pigmentosa
Massengill, M. T., & Lewin, A. S. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000383 · Cited by 20
Characterization of RNA editing and gene therapy with a compact CRISPR-Cas13 in the retina
Kumar, S., Hsiao, Y.-W., Wong, V. H. Y., Aubin, D., Wang, J.-H., Lisowski, L., Rakoczy, E. P., Li, F., Alarcon-Martinez, L., Gonzalez-Cordero, A., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2408345121 · Cited by 19
“7m8 serotype ( 28 ).”
Ho, M. T., Kawai, K., Abdo, D., Comanita, L., Ortín-Martínez, A., Ueno, Y., Tsao, E., Rastgar‐Moghadam, A., Xue, C., Cui, H., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03679-3 · Cited by 17
A Comparative Analysis of Models for AAV-Mediated Gene Therapy for Inherited Retinal Diseases
Alsalloum, A., Gornostal, E. A., Mingaleva, N., Pavlov, R. E., Kuznetsova, E., Antonova, E., Nadzhafova, A., Колотова, Д. Е., Кадышев, В. В., Mityaeva, O. N., et al. (2024) · Cells · doi:10.3390/cells13201706 · Cited by 20
“Furthermore, the administration of a medium containing AAVs to ROs mimics subretinal injection techniques, since in this case AAVs gain access to outer retinal cells [123].”
BackgroundRetinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models
McDonald, A. J., & Wijnholds, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052887 · Cited by 19
“Multiple studies have detailed the tropism of AAV serotypes in retinal organoids, demonstrating their utility as platforms for AAV-delivered gene supplementation [38,39, 41,108–112].”
BackgroundHanlon, K. S., Cheng, M. L., Ferrer, R. M., Ryu, J. R., Lee, B., de la Cruz, D., Patel, N. J., Espinoza, P., Santoscoy, M. C., Gong, Y., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.05.040 · Cited by 14
Tounekti, O., Prior, S., Wassmer, S., Xu, J., Wong, A., Fang, X., Sonderegger, I., Smeraglia, J., Huleatt, J. W., Loo, L., et al. (2025) · Bioanalysis · doi:10.1080/17576180.2024.2439229 · Cited by 17
Generation of Human iPSC-Derived Retinal Organoids for Assessment of AAV-Mediated Gene Delivery
Tso, A., da Costa, B. L., Fehnel, A., Levi, S. R., Jenny, L. A., Ragi, S. D., Li, Y., & Quinn, P. M. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2651-1_27 · Cited by 13
Adeno-Associated Virus-Mediated Gene Therapy
Zaman, H., Khan, A. U., Khan, K., Toheed, S., Abdullah, M., Zeeshan, H. M., Hameed, A., Umar, M., Shahid, M., Malik, K. A., et al. (2023) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2023048135 · Cited by 12
Sauter, M. M., Noel, H. R., Sinha, D., Nelson, E. C., Xiong, M. N., Gamm, D. M., & Brandt, C. R. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110478 · Cited by 10
Toward Retinal Organoids in High-Throughput
Spirig, S. E., & Renner, M. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041275 · Cited by 12
Na, H.-J., Kwon, J., Kim, S.-H., Ahn, J., Kwon, O.-S., & Chung, K. (2024) · International Journal of Stem Cells · doi:10.15283/ijsc23071 · Cited by 9
“Therefore, AAV transduction efficiency in retinal organoids has been assessed at various stages of maturation, including D42 (14), D140 (15), and D200 (16) depending on the specific target cell type for transgene delivery by AAV.”
BackgroundSchmied, V., Korkut-Demirbaş, M., Venturino, A., Maya-Arteaga, J. P., & Siegert, S. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03366-x · Cited by 8
“The AAV encoded for the calcium sensor GCAMP6s under the control of the ubiquitous EF1α promoter [10, 112], resulting in a broad (See figure on next page.)”
Corti, S., Kim, K. H., Chen, T., Botezatu, A., Cora, V., Ma, K., Pashkovskaia, N., Vergara, A. B., Sperlich, D., Dave, K., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102244 · Cited by 10
Organoid transduction using recombinant adeno‐associated viral vectors: Challenges and opportunities
Belova, L., Лавров, А. В., & Smirnikhina, S. (2022) · BioEssays · doi:10.1002/bies.202200055 · Cited by 6
“[105] The expression of these receptors explains the high tropic properties of rAAV2-7m8,[86,87] a mutant recombinant”
BackgroundInfluentialAAV-mediated exon skipping therapy for Usher syndrome, type 2A
Mauriac, S. A., Lee, J., Zhang, J., Jin, J., Nist-Lund, C. A., Martin, C. A., Muhlenbrock, C. R. V., O’Malley, S., Chaves, M. G., Madison, M. A., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.038 · Cited by 6
Suárez-Herrera, N., Riswick, I. B., Vázquez-Domínguez, I., Duijkers, L., Karjosukarso, D. W., Piccolo, D., Bauwens, M., Baere, E. B. W. D., Cheetham, M. E., Garanto, A., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.019 · Cited by 5
Retinal organoids mirror CRISPR-Cas9 gene editing efficiency observed in vivo
Pulman, J., Malki, H., Oudin, P., Aydin, E., Tran, S., Visticot, L., Robert, C., Cian, A. D., As, M., Goureau, O., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101627 · Cited by 5
Self-citationViral Vector Technologies and Strategies: Improving on Nature
Croze, R. H., Kotterman, M. A., Burns, C. H., Schmitt, C. E., Quezada, M., Schaffer, D. V., Kirn, D. H., & Francis, P. J. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000361 · Cited by 5
Palmieri, L., Bimbi, G., Ferrand, M., Marcello, M., Pili, L., Hong, A. V., Jaber, A., El‐Khoury, R., Brochier, G., Bigot, A., et al. (2026) · npj Regenerative Medicine · doi:10.1038/s41536-025-00445-8 · Cited by 4
“Tissue engineering applications for AAV gene therapy have been exploited mostly in the context of retinopathies 20,23 – 25 , while only limitedly explored for muscular disorders.”
Xu, P., Guo, F., Wang, Y., Chen, G., Song, X., Luo, B. Y., Zheng, D., Gao, G., Yin, W., Zhang, S., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.02.040 · Cited by 4
Shen, W., Shao, A., Zhou, W., Lou, L., Grzybowski, A. E., Jin, K., & Ye, J. (2023) · Cell Transplantation · doi:10.1177/09636897231214321 · Cited by 4
Evaluating therapeutic potential of NR2E3 doses in the rd7 mouse model of retinal degeneration
McNamee, S. M., Akula, M., Love, Z., Nasraty, N., Nystuen, K., Singh, P., Upadhyay, A. K., DeAngelis, M. M., & Haider, N. B. (2024) · Scientific Reports · doi:10.1038/s41598-024-67095-6 · Cited by 4
Kelley, R. A., & Wu, Z. (2023) · Vision Research · doi:10.1016/j.visres.2023.108269 · Cited by 5
Optogenetic approaches to gene therapy for vision restoration in retinal degenerative diseases
Mohanty, S. K., Idigo, C., Ayyagari, A. L., & Narcisse, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819291-7.00004-6 · Cited by 4
Belova, L., Demchenko, A. G., Erofeeva, A., Kochergin-Nikitsky, K. S., Zubkova, O. V., Popova, O. D., Ozharovskaia, T. A., Salikhova, D. I., Efremova, A. S., Лавров, А. В., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13040879 · Cited by 2
3D Quantification of Viral Transduction Efficiency in Living Human Retinal Organoids
Rogler, T. S., Salbaum, K. A., Brinkop, A. T., Sonntag, S. M., James, R. E., Shelton, E., Thielen, A., Rose, R., Babutzka, S., Klopstock, T., et al. (2025) · Small Methods · doi:10.1002/smtd.202401050 · Cited by 2
“[18] When transduction efficiency is evaluated this way, few transduced cells with a bright fluorescence signal and many transduced cells with low fluorescence intensity yield the same result (Figure 1B).”
InfluentialPalmieri, L., Pili, L., Jaber, A., Hong, A. V., Marcello, M., El‐Khoury, R., Brochier, G., Bigot, A., Israeli, D., Richard, I., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.26.550063 · Cited by 2
Na, H.-J., Shin, Y., Kim, S.-H., Jang, S. P., Son, M. J., Choi, Y. M., Jeon, H. G., Kwon, O.-S., & Chung, K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336164 · Cited by 1
Electroporation-based gene delivery and whole-organoid imaging in human retinal organoids
Flohr, K., Janeček, M., Wang, L., Valle, V., Pi, S., Peixoto, R. T., & da Silva, S. (2025) · Developmental Biology · doi:10.1016/j.ydbio.2025.11.016 · Cited by 2
Busson, S. L., Naeem, A., Ferrara, S., Sarcar, S., Adefila-Ideozu, T., Wells, S., Alami, S. E., Boot, J. R., Sladen, P. E., Michaelides, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010449 · Cited by 1
“…a clinical track record for subretinal delivery to retinal cells [18] and AAV7m8, an engineered AAV2 variant developed for intravitreal gene delivery, which we and others have shown to more efficiently transduce human photoreceptors in RO cultures compared to natural AAV serotypes [15,16,19,20].”
Galdikaitė, E., Krušnauskas, R., Henderson, E., & Bujakowska, K. M. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101462 · Cited by 2
Hurnikova, J., Venkatesan, J. K., Liu, W., Madry, H., Cucchiarini, M., & Petrovová, E. (2026) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2026.100404 · Cited by 1
Deep-sequencing-guided library screening and profiling of AAV capsids in the primate retina
Fouani, Y., Blazevic, D., Oti, M., Becker, R., Strobel, B., Schönberger, T., Stephan, M., Wichert, S., Reichel, F. F., Seitz, I. P., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201764 · Cited by 1
“39,62,63 Notably, while species-specific differences have been reported for systemically delivered AAVs, 59,64,65 AAV2-GAYPKSP represents to our knowledge the first published example failing to translate from rodents to NHPs after IVT administration.”
Albini, S., Palmieri, L., Pili, L., Jaber, A., Hong, A. V., Moula, M., El‐Khoury, R., Brochier, G., Bigot, A., Israeli, D., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-4270736/v1 · Cited by 1
Benefits and Shortcomings of Laboratory Model Systems in the Development of Genetic Therapies
Bucher, K., Rodríguez‐Bocanegra, E., & Fischer, M. D. (2022) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-1757-9879
“The development of novel vectors such as AAV2-7m8 resulted in an increased transduction efficiency of AAV in RPE cells [49].”
BackgroundRetinal Organoid Development: Disease Modeling and Therapeutic Strategies
Sharma, K., Pawlick, J. S., & Busskamp, V. (2025) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-031-94101-6_8 · Cited by 1
Ho, M. T., Kawai, K., Abdo, D., Comanita, L., Ortín-Martínez, A., Ueno, Y., Tsao, E., Rastgar‐Moghadam, A., Xue, C., Cui, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26693539
AAV-mediated expression of Secreted Klotho as a therapeutic strategy for Alzheimer's disease
Blanch, R. (2023) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) · Cited by 2
Microphysiological systems to accelerate and de-risk AAV gene therapy development
Tornabene, P., Berreur, E., Roth, A., & Kasendra, M. J. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115841
Elia, M., Pauzuolyte, V., Γεωργίου, Μ., Basche, M., Hansohn, C., Vasconcelos, E. J. R., Atkinson, R., Grellscheid, S., Johnson, C. A., Hilgen, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.14.718379
Ehrenreich, N., Metais, T., & Garita‐Hernandez, M. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5198-8_9
Self-citationTransduction of AAV Vectors in iPSC-Derived Retinal Organoids
Aubin, D., & Gonzalez-Cordero, A. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5198-8_10
Liang, Y., Sun, X., Chen, H., Cui, Z., Li, W., Guo, Y., Chen, Y., Mao, S., Duan, C., Zhang, R., et al. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102316
Ye, K., Zhang, S., Xu, P., Song, X., Wang, Y., & Zhong, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135643
Onishi, A., Sakuma, T., Mandai, M., Watanabe, T., Endo, T. A., Nomura, W., Ishimaru, A., Inoue, K., Sho, J., Ohigashi, Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.13.738123
abdelnaby, M., Galiakberova, A. A., & Dashinimaev, E. B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156846
“Garita-Hernandez et al. showed that the efficiency of transduction correlated directly with the presence of the corresponding cell-surface receptors at the time of infection for four serotypes (AAV2, AAV2-7m8, AAV8, AAV9) [29].”
Metadata
- Authors
- Garita-Hernandez, M., Routet, F., Guibbal, L., Khabou, H., Toualbi, L., Riancho, L., Reichman, S., Duebel, J., Sahel, J.-A., Goureau, O., & Dalkara, D.
- Affiliations
- Sorbonne Université,, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, France
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Dalkara, Deniz
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-02-03
- Volume
- 21
- Issue
- 3
- Pages
- 994
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7036814
- OpenAlex
- W3003530398
- Cited by
- 82
- References
- 37
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 12 · 2023: 11 · 2022: 9 · 2021: 15 · 2020: 9
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Funders
- European Research Council (OPTOGENRET, 309776, REGNETHER 639888)
- Marie Curie CIG (334130, RETINAL GENE THERAPY)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus vectors, retinal organoids, human induced pluripotent stem cells, retinal pigment epithelial cells, transduction efficiency, cell surface receptors, long-term gene expression, retinal degeneration, retinal development
- MeSH terms
- Dependovirus, Animals, Genetic Vectors, Humans, Mice, Inbred C57BL, Organoids, Receptors, Cell Surface, Retina, Transduction, Genetic, Genetic Variation, Genetic Therapy, Gene Transfer Techniques, Transgenes, Green Fluorescent Proteins, Mice, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.